Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
APOC3 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
APOC3 target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
ANGPTL3 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
ANGPTL3 target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
PCSK9 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
PCSK9 target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
SERPINC1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
SERPINC1 target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
KLKB1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
KLKB1 target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
F12 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
F12 target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
F11 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
F11 target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
F10 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
F10 target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
F2 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
F2 target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
CFH Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
CFH target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
CFD Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
CFD target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
MASP2 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
MASP2 target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.